Frontlight ResearchEarly access
CompletedNo phase
Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)
Key facts
- Who runs it
- Sahlgrenska University Hospital
- Where
- Sweden2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 17 Oct 2022
- Ended
- 30 May 2025
- Type of study
- Interventional
- Treatments tested
- Gut-directed hypnotherapy
- Record updated
- 12 January 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- IBS diagnosis
Who cannot take part
- Organic GI disease
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Adult IBS patients with symptoms refractory to standard medical treatment will receive online nurse-administered, gut-directed hypnotherapy in groups. The primary outcome measure was change in gastro-intestinal symptom severity. Secondary outcomes are GI-specific anxiety, general anxiety and depression, quality of life, and extracolonic symptom severity. Usability of the digital platform as well as patient treatment satisfaction will also be assessed.
The group in the trial
- Nurse-delivered, gut-directed hypnotherapyOther group
Treatment: Gut-directed hypnotherapy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 12 January 2026